Q4 2015

Source filing unavailable

Q4 2015 · —

derived · Computed from the longer spans the company filed.

Revenue

$227.94M

derived−0.6% vs Q4 2014

Net Income

$68.62M

derivedN/M vs Q4 2014

EPS, diluted—Not derived. Share counts vary by quarter.

Operating Incomederived$101,319,000N/M

Same quarter

Metric	Q4 2015derived from reported figures	Q4 2014derived from reported figures	Q4 2013derived from reported figures	Q4 2012derived from reported figures
Revenue	$227.94M	$229.40M	$146.87M	$131.94M
Net Income	$68.62M	-$69.80M	-$61.99M	-$53.01M

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

BioMarin Pharmaceutical Inc · CIK 1048477 · Engraved from SEC EDGAR